Where does Topivert Pharma Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Topivert Pharma Limited ranks #11,841 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Topivert Pharma Limited hold?

Topivert Pharma Limited holds 26 US utility patents granted between 2015 and 2021, spanning 6 technology areas.

What is Topivert Pharma Limited's Innovation Score?

Topivert Pharma Limited has an Innovation Score of 29.5 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Topivert Pharma Limited focus on?

Topivert Pharma Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 26 patents, ranking #760 of 6,058 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Topivert Pharma Limited's patent grant rate increasing or decreasing?

Topivert Pharma Limited's recent grant velocity is -87% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Topivert Pharma Limited's patents?

Topivert Pharma Limited's patents average 15.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Topivert Pharma Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Topivert Pharma Limited

USPTO PatentsView assignee record - 26 granted patents across 6 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Topivert ranks #11,841 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 6 technology areas.

#11,841
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.5/100): 15.8
avg claims per patent: -87%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11841 · Foreign Corporation #11,841 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,841/49,997
PHOTO-FINISH TI Automotive…
CPC-NARROW A61P · 6 areas
INNOV-THIN 29.5/100
CLAIMS-RICH 15.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -87% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: TI Automotive (Fuldabrück) GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Topivert’s 29.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (39%) Velocity 0.0 pts (0%) Breadth 8.7 pts (29%) Claim depth 9.5 pts (32%)

Qualcomm Incorporated · highest

85
LF Centennial · near

30
Turbine Powered… · near

30
Perpetuum · near

30
Spritz · near

30
Topivert Pharma · this assignee

30
3D Lighting… · lowest

7

What this shows Topivert's Innovation Score is 29.5/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Topivert?

Each dot is one of Topivert’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Topivert’s own 15.8 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Topivert vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Topivert's grants concentrate

Topivert Pharma Limited is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (11 grants) versus a trough of 1 in 2015. By volume, Topivert sits between TI Automotive (Fuldabrück) GmbH and TYR Tactical, LLC.

TI Automotive (Fu…

26
Tietex Internatio…

26
Tod's S P A

26
Tokuden

26
Toptica Photonics

26
Trinity North Ame…

26
Tubitak

26
TYR Tactical

26
Topivert Pharma ◀

26

What this shows Topivert holds 26 patents at rank #11,835, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Topivert

By rank, the assignees closest to #11,835 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Topivert's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Topivert, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Topivert ranks #760 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (30 here).

Perpetuum Ltd 30 Spritz, Inc. 30 LF Centennial Ltd. 30 Turbine Powered Technology, LLC 30

Topivert's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Topivert Pharma Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.8%
2016	4	15.4%
2017	11	42.3%
2018	3	11.5%
2019	4	15.4%
2020	2	7.7%
2021	1	3.8%

Which technologies does Topivert Pharma Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 26

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 26

C07D - Heterocyclic Compounds 25

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 13

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 5

C07C - Acyclic OR Carbocyclic Compounds 5

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Topivert Pharma Limited's patent record in context - here's where to go next.

Topivert Pharma Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #11,841 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Topivert Pharma Limited against TI Automotive (Fuldabrück) GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.